Navigation Links
Reportlinker Adds Asia-Pacific Drug Delivery Devices Market Outlook to 2017
Date:6/8/2011

ach of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the Asia-Pacific Drug Delivery Devices market..

- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, AstraZeneca PLC, Terumo Corporation, Sunovion, NIPRO CORPORATION and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the Asia-Pacific Drug Delivery Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

To order this report:

: Asia-Pacific Drug Delivery Devices Market Outlook to 2017

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

CONTACT
Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626


'/>"/>
SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Reportlinker Adds Hearing Aid Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2017
2. Reportlinker Adds Renal Dialysis Equipment - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
3. Reportlinker Adds Cardiovascular Monitoring and Diagnostic Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4. Reportlinker Adds Cancer Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2017
5. Reportlinker Adds Myelodysplastic Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2017
6. Reportlinker Adds Interventional Neurology - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
7. Reportlinker Adds Chinas Guidebook for Pharmaceutical Patent Protection
8. Reportlinker Adds Greece Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2017
9. Reportlinker Adds Global Top 10 Pharmaceutical Companies: Industry, Financial and SWOT Analysis
10. Reportlinker Adds the Future of In Vitro and In Vivo Diagnostic Integration
11. Reportlinker Adds Global Market for Hormonal Contraceptives and Infertility Drugs, 2011-2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015 Research and Markets ... the "Market Assessment of Respiratory Diagnostics in ... their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,This research ... diagnostics market in the United States ... The service provides detailed analysis of the current ...
(Date:5/21/2015)... -- CryoLife, Inc. (NYSE: CRY ), a leading medical ... vascular surgery, announced today that its Board of Directors ... quarter 2015 of $0.03 per share of common stock ... will be paid on June 19, 2015 to all ... The ex-dividend date for the quarterly dividend is June ...
(Date:5/21/2015)... , May 21, 2015  (MUSE Booth # ... Health Record (EHR) is invaluable in any hospital ... are now a requirement and mainstream in healthcare, ... into the EHR is gaining traction in MEDITECH ... Holmes, RN, Site Project Manager & Clinical Analyst ...
Breaking Medicine Technology:United States and Europe Respiratory Diagnostics Market Assessment 2015 2CryoLife Announces Quarterly Cash Dividend for the Second Quarter 2015 2Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
... 2012 Lilly Diabetes today announced a donation of ... The contribution will support the Foundation,s mission to empower ... lives to the fullest. The Foundation will use the ... 1 diabetes as well as conference scholarships for families ...
... April 3, 2012 Watson Pharmaceuticals, Inc. (NYSE: ... District Court for the District of Delaware has ruled ... 7,410,978 (the ,978 Patent), 7,759,359 (the ,359 Patent), 7,781,448 ... (the ,635 Patent) for Sanctura XR® (trospium chloride extended-release ...
Cached Medicine Technology:Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 2Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012 3Watson Confirms Favorable District Court Ruling in Generic Sanctura XR® Patent Suit 2
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... In an effort to support the ... offering to donate $5 dollars for every maintenance call, ... water softening system. Customers have their needs serviced, and ... business; and the Special Olympics receives money. Hence the ... over 4.4 million athletes, and boasts a myriad of ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 A new ... featuring experts in the field of Physical Therapy. ... that takes the mystery out of physical therapy and ... range of motion for a variety of ailments and ... establish a personalized exercise plan that enhances daily activities ...
(Date:5/22/2015)... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... religious leaders to make changes in order to achieve peace ... discusses the history of war, how it started, why it ... mankind was created to lead peaceful, joyful lives, very much ... “Yahweh created mankind, according to His Plan, which is still ...
(Date:5/21/2015)... 21, 2015 World Patent Marketing, a ... the Troll Motor Guide, a boat patent that aims ... "The recreational boating industry has reached an annual revenue ... Creative Director of World Patent Marketing , "Americans ... predicts continued steady growth of seven percent in new ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:Yisrayl Hawkins Calls on All Religions to Wake Up and Make Drastic Changes to End Suffering in New Letter 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3
... ... Mark Merritt released the following statement on today’s Federal Workforce, Postal Service, and ... the Federal Employees Health Benefits Program (FEHBP) , ... Washington, DC (Vocus) February 23, 2010 ...
... exposure time , TUESDAY, Feb. 23 (HealthDay News) -- ... as much as 91 percent less radiation than standard ... generated great enthusiasm in recent years, due to its ... coronary artery disease. However, that enthusiasm has been tempered ...
... improve life expectancy, study finds , TUESDAY, Feb. ... and MRI appears to be a cost-effective way to ... breast cancer, U.S. researchers say. , In the new ... Hospital in Boston, and colleagues used statistical modeling to ...
... likely to develop dementia than non-hospitalized, study finds , ... been hospitalized have an increased risk of cognitive decline. , ... 1994 through 2007 on 2,929 people, aged 65 and older, ... study. During an average follow-up of 6.1 years, 1,287 were ...
... shortages, researchers say, , TUESDAY, Feb. 23 (HealthDay News) -- Although ... sharp decline in the average number of hours they work each ... the average work week of doctors remained steady, but between 1996 ... dropped nearly four hours a week -- from 54.9 to 51 ...
... ... ... ... ...
Cached Medicine News:Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 2Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 3Health News:PCMA: Proposed Overhaul of FEHBP Pharmacy Benefit,Would Undermine Cost-Saving Tools, ,Reduce Choices for 8 Million Americans, 4Health News:New Heart CT Scans Deliver Far Less Radiation: Study 2Health News:Mammogram Plus MRI Seems Cost-Effective in High-Risk Women 2Health News:Hospital Stays May Spur Brain Decline in Seniors 2Health News:Doctors Working Less, Earning Less 2Health News:Doctors Working Less, Earning Less 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 2Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 3Health News:Stopain Labels Featuring Arthritis Foundation Sponsorship Now Appearing on Retail Shelves 4
CRP Liquid Conrtols level 3...
Therapeutic Drug Calibrator Series...
The IRN method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of iron in serum....
The AST method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma...
Medicine Products: